NCT04315688 - A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia | Biotech Hunter

Enrollment

494

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

August 2, 2021

Study Completion Date

August 2, 2021

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec

Treatment with Tresiba® with or without anti-diabetes medication (as per local label), as prescribed by the participant's physician. The study population will include adult patients with type 2 diabetes, both insulin naïve and previously insulin treated, for whom the treating physician has decided to initiate treatment with Tresiba®, independent of the decision to include the patient in the study.

Trial Locations (40)

111401

Novo Nordisk Investigational Site, Moscow

117036

Novo Nordisk Investigational Site, Moscow

129226

Novo Nordisk Investigational Site, Moscow

140203

Novo Nordisk Investigational Site, Voskresensk

141300

Novo Nordisk Investigational Site, Sergiyev Posad

141707

Novo Nordisk Investigational Site, Moscow Region, Dolgoprudny

143003

Novo Nordisk Investigational Site, Odintsovo, Moscow Region

153012

Novo Nordisk Investigational Site, Ivanovo

167981

Novo Nordisk Investigational Site, Syktyvkar

193231

Novo Nordisk Investigational Site, Saint Petersburg

194358

Novo Nordisk Investigational Site, Saint Petersburg

195256

Novo Nordisk Investigational Site, Saint-Peterburg

199004

Novo Nordisk Investigational Site, Saint-Peterburg

242610

Novo Nordisk Investigational Site, Bryansk

248002

Novo Nordisk Investigational Site, Kaluga

297200

Novo Nordisk Investigational Site, Sovetskiy

297600

Novo Nordisk Investigational Site, Belogorsk

298500

Novo Nordisk Investigational Site, Alushta

299011

Novo Nordisk Investigational Site, Sevastopol’

300035

Novo Nordisk Investigational Site, Tula

344004

Novo Nordisk Investigational Site, Rostov-on-Don

350000

Novo Nordisk Investigational Site, Krasnodar

358000

Novo Nordisk Investigational Site, Elista

398043

Novo Nordisk Investigational Site, Lipetsk

410005

Novo Nordisk Investigational Site, Saratov

410033

Novo Nordisk Investigational Site, Saratov

420073

Novo Nordisk Investigational Site, Kazan'

440039

Novo Nordisk Investigational Site, Penza

440066

Novo Nordisk Investigational Site, Penza

443111

Novo Nordisk Investigational Site, Samara

446100

Novo Nordisk Investigational Site, Chapayevsk

450038

Novo Nordisk Investigational Site, Ufa

452320

Novo Nordisk Investigational Site, Dyurtyuli

454048

Novo Nordisk Investigational Site, Chelyabinsk

455016

Novo Nordisk Investigational Site, Magnitogorsk

603155

Novo Nordisk Investigational Site, Nizhny Novgorod

606210

Novo Nordisk Investigational Site, Lyskovo

607060

Novo Nordisk Investigational Site, Vyksa

660021

Novo Nordisk Investigational Site, Krasnoyarsk

660062

Novo Nordisk Investigational Site, Krasnoyarsk